Literature DB >> 29218370

Differentiation of residual/recurrent gliomas from postradiation necrosis with arterial spin labeling and diffusion tensor magnetic resonance imaging-derived metrics.

Ahmed Abdel Khalek Abdel Razek1, Lamiaa El-Serougy2, Mohamed Abdelsalam3, Gada Gaballa2, Mona Talaat2.   

Abstract

PURPOSE: The aim of this study is to differentiate recurrent/residual gliomas from postradiation changes using arterial spin labeling (ASL) perfusion and diffusion tensor imaging (DTI)-derived metrics.
METHODS: Prospective study was conducted upon 42 patients with high-grade gliomas after radiotherapy only or prior to other therapies that underwent routine MR imaging, ASL, and DTI. The tumor blood flow (TBF), fractional anisotropy (FA), and mean diffusivity (MD) of the enhanced lesion and related edema were calculated. The lesion was categorized as recurrence/residual or postradiation changes.
RESULTS: There was significant differences between residual/recurrent gliomas and postradiation changes of TBF (P = 0.001), FA (P = 0.001 and 0.04), and MD (P = 0.001) of enhanced lesion and related edema respectively. The area under the curve (AUC) of TBF of enhanced lesion and related edema used to differentiate residual/recurrent gliomas from postradiation changes were 0.95 and 0.93 and of MD were 0.95 and 0.81 and of FA were 0.81 and 0.695, respectively. Combined ASL and DTI metrics of the enhanced lesion revealed AUC of 0.98, accuracy of 95%, sensitivity of 93.8%, specificity of 95.8%, positive predictive value (PPV) of 93.8%, and negative predictive value (NPV) of 95.8%. Combined metrics of ASL and DTI of related edema revealed AUC of 0.97, accuracy of 92.5%, sensitivity of 93.8%, specificity of 91.7%, PPV of 88.2%, and NPV of 95.7.
CONCLUSION: Combined ASL and DTI metrics of enhanced lesion and related edema are valuable noninvasive tools in differentiating residual/recurrent gliomas from postradiation changes.

Entities:  

Keywords:  Arterial spin labeling; Diffusion tensor; Edema; Recurrence

Mesh:

Substances:

Year:  2017        PMID: 29218370     DOI: 10.1007/s00234-017-1955-3

Source DB:  PubMed          Journal:  Neuroradiology        ISSN: 0028-3940            Impact factor:   2.804


  33 in total

1.  Comparison of 3 Tesla proton MR spectroscopy, MR perfusion and MR diffusion for distinguishing glioma recurrence from posttreatment effects.

Authors:  James R Fink; Robert B Carr; Eiji Matsusue; Ramesh S Iyer; Jason K Rockhill; David R Haynor; Kenneth R Maravilla
Journal:  J Magn Reson Imaging       Date:  2011-10-14       Impact factor: 4.813

Review 2.  Imaging of the Posttherapeutic Brain.

Authors:  Bruno A Telles; Francesco D'Amore; Alexander Lerner; Meng Law; Mark S Shiroishi
Journal:  Top Magn Reson Imaging       Date:  2015-06

Review 3.  Advanced MRI Techniques in the Monitoring of Treatment of Gliomas.

Authors:  Harpreet Hyare; Steffi Thust; Jeremy Rees
Journal:  Curr Treat Options Neurol       Date:  2017-03       Impact factor: 3.598

4.  Response assessment in high-grade glioma: tumor volume as endpoint.

Authors:  Raymond Huang
Journal:  Neuro Oncol       Date:  2017-06-01       Impact factor: 12.300

5.  Response Assessment in Neuro-Oncology criteria, contrast enhancement and perfusion MRI for assessing progression in glioblastoma.

Authors:  Fatima Tensaouti; Jonathan Khalifa; Amélie Lusque; Benjamin Plas; Jean Albert Lotterie; Isabelle Berry; Anne Laprie; Elizabeth Cohen-Jonathan Moyal; Vincent Lubrano
Journal:  Neuroradiology       Date:  2017-08-25       Impact factor: 2.804

6.  Distinction between postoperative recurrent glioma and radiation injury using MR diffusion tensor imaging.

Authors:  Jun-Ling Xu; Yong-Li Li; Jian-Min Lian; She-wei Dou; Feng-Shan Yan; Hui Wu; Da-peng Shi
Journal:  Neuroradiology       Date:  2010-06-23       Impact factor: 2.804

7.  Serial diffusion tensor imaging for early detection of radiation-induced injuries to normal-appearing white matter in high-grade glioma patients.

Authors:  Tuva R Hope; Jonas Vardal; Atle Bjørnerud; Christopher Larsson; Marius R Arnesen; Raimo A Salo; Inge R Groote
Journal:  J Magn Reson Imaging       Date:  2014-01-08       Impact factor: 4.813

8.  Distinguishing recurrent high-grade gliomas from radiation injury: a pilot study using dynamic contrast-enhanced MR imaging.

Authors:  Sotirios Bisdas; Thomas Naegele; Rainer Ritz; Artemisia Dimostheni; Christina Pfannenberg; Matthias Reimold; Tong San Koh; Ulrike Ernemann
Journal:  Acad Radiol       Date:  2011-03-21       Impact factor: 3.173

9.  Arterial spin labeling: Pathologically proven superiority over conventional MRI for detection of high-grade glioma progression after treatment.

Authors:  Eric Nyberg; Justin Honce; Bette K Kleinschmidt-DeMasters; Brian Shukri; Sarah Kreidler; Lidia Nagae
Journal:  Neuroradiol J       Date:  2016-08-19

10.  Different diagnostic values of imaging parameters to predict pseudoprogression in glioblastoma subgroups stratified by MGMT promoter methylation.

Authors:  Ra Gyoung Yoon; Ho Sung Kim; Wooyul Paik; Woo Hyun Shim; Sang Joon Kim; Jeong Hoon Kim
Journal:  Eur Radiol       Date:  2016-04-05       Impact factor: 5.315

View more
  36 in total

1.  Accuracy of diffusion-weighted imaging-magnetic resonance in differentiating functional from non-functional pituitary macro-adenoma and classification of tumor consistency.

Authors:  Morteza Sanei Taheri; Farnaz Kimia; Mersad Mehrnahad; Hamidreza Saligheh Rad; Hamidreza Haghighatkhah; Afshin Moradi; Anahita Fathi Kazerooni; Mohammadreza Alviri; Abdorrahim Absalan
Journal:  Neuroradiol J       Date:  2018-12-03

2.  Diffusion tensor imaging of the optic disc in idiopathic intracranial hypertension.

Authors:  Ahmed Abdel Khalek Abdel Razek; Nihal Batouty; Wesam Fathy; Rania Bassiouny
Journal:  Neuroradiology       Date:  2018-08-22       Impact factor: 2.804

3.  Accuracy of apparent diffusion coefficient values and magnetic resonance imaging in differentiating suprasellar germinomas from chiasmatic/hypothalamic gliomas.

Authors:  Theeraphol Panyaping; Piyakarn Taebunpakul; Oranan Tritanon
Journal:  Neuroradiol J       Date:  2020-03-20

4.  Arterial spin labeling perfusion-weighted MR imaging: correlation of tumor blood flow with pathological degree of tumor differentiation, clinical stage and nodal metastasis of head and neck squamous cell carcinoma.

Authors:  Ahmed Abdel Khalek Abdel Razek; Nadia Nada
Journal:  Eur Arch Otorhinolaryngol       Date:  2018-03-27       Impact factor: 2.503

5.  Diagnostic accuracy of diffusion tensor imaging in differentiating malignant from benign compressed vertebrae.

Authors:  Ahmed Abdel Khalek Abdel Razek; Fatma Mohamed Sherif
Journal:  Neuroradiology       Date:  2019-09-06       Impact factor: 2.804

6.  Evaluation of cortical thickness and brain volume on 3 Tesla magnetic resonance imaging in children with frontal lobe epilepsy.

Authors:  Feride Kural Rahatli; Taner Sezer; Arzu Ceylan Has; Ahmet Muhtesem Agildere
Journal:  Neurol Sci       Date:  2019-12-04       Impact factor: 3.307

7.  Arterial spin labeling imaging correlates with the angiographic and clinical vascularity of vestibular schwannomas.

Authors:  Yujiro Tanaka; Michihiro Kohno; Takao Hashimoto; Nobuyuki Nakajima; Hitoshi Izawa; Hirofumi Okada; Norio Ichimasu; Ken Matsushima; Tomoya Yokoyama
Journal:  Neuroradiology       Date:  2020-01-09       Impact factor: 2.804

Review 8.  Intracranial long-term complications of radiation therapy: an image-based review.

Authors:  Carrie M Carr; John C Benson; David R DeLone; Felix E Diehn; Dong Kun Kim; Kenneth W Merrell; Alex A Nagelschneider; Ajay A Madhavan; Derek R Johnson
Journal:  Neuroradiology       Date:  2021-01-04       Impact factor: 2.804

9.  Radiotherapy in adult low-grade glioma: nationwide trends in treatment and outcomes.

Authors:  R S Nunna; S Khalid; J S Ryoo; A Sethi; R W Byrne; A I Mehta
Journal:  Clin Transl Oncol       Date:  2020-07-20       Impact factor: 3.405

Review 10.  Diagnostic Performance of PET and Perfusion-Weighted Imaging in Differentiating Tumor Recurrence or Progression from Radiation Necrosis in Posttreatment Gliomas: A Review of Literature.

Authors:  N Soni; M Ora; N Mohindra; Y Menda; G Bathla
Journal:  AJNR Am J Neuroradiol       Date:  2020-08-27       Impact factor: 3.825

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.